ASML vs FDMT · P/E 57, $665.37B cap vs rev $37.0K
ASML Holding NV ADR (ASML) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
ASML does not have a complete income-statement cache yet.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the ASML and FDMT stock pages for the full models.
Not investment advice.